TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
Mar 10, 2021: TFF Pharmaceuticals Fourth Quarter and Full-Year 2020 Financial and Business Results Conference
TFF Pharmaceuticals Corporate Overview – March 2020
TFF Pharmaceuticals to Hold First Quarter 2021 Financial and Business Results Conference Call on May 13, 2021
May 4, 2021
TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters
April 13, 2021
March 26, 2021